Delivery Order SPE2DB22D3301-SPE2DB25FZ0FC
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Lidocaine 5% patches in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,866.10 and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation and was awarded competitively. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Lidocaine 5% Patch 30s by the Defense Logistics Agency (DLA) on July 21, 2025. This firm fixed-price, competitively awarded contract has a ceiling value of $1,155.74 and an ultimate completion date of July 22, 2025. The award was not designated as a set-aside contract and represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $1,509.44. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $16,405.94, represents a non-competitive award with an ultimate completion date of August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $10,311.22. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is set to be completed by August 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,504.37 for Lidocaine 5% Patch (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lidocaine 5% Patch 30-count units, valued at $1,134.20. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The contract was competitively awarded with no set-aside designation and will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $7,723.82. This firm fixed-price, non-set-aside contract is part of the company's broader relationship with the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies to support military and federal healthcare systems. The order is scheduled for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $8,028.28. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order carries a firm fixed price structure with an ultimate completion date...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0FCDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 28, 2025, for the supply of Lidocaine 5% patches (30-count units). The contract, classified as a firm fixed-price delivery order with a ceiling value of $4,301.46, is not set-aside and was competitively awarded. The ultimate completion date is August 29, 2025, with performance occurring at the awardee's Conshohocken, Pennsylvania location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime IDV encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard. The current delivery order for Lidocaine patches represents a routine fulfillment of pain management pharmaceuticals under this expansive contract framework, demonstrating the vendor's role as a critical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/28/25 |